DARA BioSciences Signs Definitive Agreement to Raise $1.2155 Million in Registered Direct Offering
17. September 2009 08:26 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 17, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with...
DARA BioSciences Announces Receipt of NASDAQ Letter Citing Non-Compliance With Minimum Bid Price Rules
17. September 2009 08:25 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 17, 2009 (GLOBE NEWSWIRE) -- On September 15, 2009, DARA BioSciences, Inc. (Nasdaq:DARA) received a notice from The NASDAQ Stock Market stating that the minimum bid price of the...
DARA BioSciences Will Present Phase 2a Study Results for KRN5500 At the "12th International Conference on the Mechanisms and Treatment of Neuropathic Pain" Meeting
15. September 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 15, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that results of its KRN5500 study have been selected for presentation at the 12th International...
DARA BioSciences Signs Definitive Agreement to Raise $2.5 Million in Registered Direct Offering
11. September 2009 10:04 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 11, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with...
DARA BioSciences Reports On SurgiVision's Co-Development Agreement With Siemens Healthcare
10. September 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Sept. 10, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that SurgiVision, Inc., a privately held company of which DARA owns approximately 7.3% of the...
DARA BioSciences, Inc. and America Stem Cell, Inc. Collaborate On Stem Cell Research
04. August 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., Aug. 4, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that the Company is collaborating with America Stem Cell ("ASC") to expand on observations from...
DARA BioSciences Receives Notification From NASDAQ Regarding Non-Compliance With Continued Listing Requirements
24. Juli 2009 16:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., July 24, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) (the "Company"), a development-stage pharmaceutical company, announced today that the Company received an...
DARA BioSciences Releases Promising Preclinical Type 2 Diabetes Data for First-in-Class DB959
14. Juli 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., July 14, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) releases, today, a summary highlighting preclinical data for DB959, its lead compound for Type 2 Diabetes (T2D)...
DARA BioSciences, Inc. Expands Its Patent Portfolio
25. Juni 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., June 25, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that as of June 11, 2009 it has gained the allowance and grant of an additional 10 patents to its...
DARA BioSciences Raises $1,397,000 Through the Sale of Common Stock and Warrants
16. Juni 2009 08:45 ET
|
DARA BioSciences, Inc.
RALEIGH, N.C., June 16, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA), announced today that on June 15, 2009, it entered into and closed a securities purchase agreement (SPA) with...